[1] Karnjanapratum, S.; You, S. Molecular characteristics of sulfated polysaccharides from Monostroma nitidum and their in vitro anticancer and immunomodulatory activities. Int. J. Biol. Macromol. 2010, 2, 311–318.
[2] Zhang, Z.; Zhang, Q.; Wang, J.; Zhang, H.; Niu, X.; Li, P. Preparation of the different derivatives of the low-molecular-weight porphyran from Porphyra haitanensis and their antioxidant activities in vitro. Int. J. Biol. Macromol. 2009, 1, 22–26.
[3] Rajeswari, A.; Varalakshmi, P. Low molecular weight heparin protection against oxalate-induced oxidative renal insult. Clin. Chim. Acta 2006, 1, 108–114.
[4] Wijesekara, I.; Pangestuti, R.; Kim, S.K. Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae. Carbohydr. Polym. 2011, 1, 14–21.
[5] Matsuda, M.; Okutani, K.; Shigeta, S. In vitro antiviral activities of sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses. Int. J. Biol. Macromol. 1995, 5, 293–297.
[6] Kardošová, A.; Machová, E. Antioxidant activity of medicinal plant polysaccharides. Fitoterapia 2006, 77, 367–373.
[7] Li, S.; Li, J. H.; Zhi, Z. J. Macromolecular properties and hypoli- pidemic effects of four sulfated polysaccharides from sea cucumbers Carbohydr. Carbohydr. Polym. 2017, 173, 330–337.
[8] Wang. X. L.; Yi, K. X.; Zhao, Y. Fucoidan inhibits amyloid-beta- inducedtoxicityin transgenic Caenorhabditis elegans by reducing the accumulation of amyloid-beta and decreasing the production of reactive oxygen species. Food Funct. 2018, 9, 552–560.
[9] Borghi, L.; Meschi, T.; Guerra, A.; Bergamaschi, E.; Mutti, A.; Novarini, A. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls. Clin. Chim. Acta 1995, 1, 1–11.
[10] Edyvane, K. A.; Hibberd, C. M.; Harnett, R. M.; Marshall, V. R.; Ryall, R. L. Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine. Clin. Chim. Acta 1987, 3, 329–338.
[11] Liu, J.; Wang, T.; Chen, J.; Wang, S.; Ye, Z. Decreased inhibitory activity of prothrombin to calcium oxalate crystallization by specific chemical modification of its gamma-carboxyglutamic acid residues. Urology 2006, 1, 201–203.
[12] Hackett, R. L.; Shevock, P. N.; Khan, S. R. Madin-Darby canine kidney cells are injured by exposure to oxalate and to calcium oxalate crystals. Urol. Res. 1994, 22, 197.
[13] Koul, H.; Kenington, L.; Honeyman, T.; Jonassen, J.; Menon, M.; Scheid, C. R. Activation of the c-myc gene mediates the mitogenic effects of Ox in LLC-PK1 cells, a line of renal epithelial cells. Kidney Int. 1996, 50, 1525–1530.
[14] Bashir, S.; Gilani, A. H. Antiurolithic effect of Bergenia ligulata rhizome: An explanation of the underlying mechanisms. J. Ethnopharmacol. 2009, 1, 106–116.
[15] Khans, R. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin. Exp. Nephrol. 2004, 8, 75–88.
[16] Guerne, P. A.; Terkeltaub, R.; uraw, B.; Lotz, M. Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum. 1989, 32, 1443–1452.
[17] Volker, V.; Tanya, N. M. Functions of TNF and its Receptors in Renal Disease: Distinct Roles in Inflammatory Tissue Injury and Immune Regulation. Semin. Nephrol. 2007, 3, 286–308.
[18] Di Paola, R.; Genovese, T.; Impellizzeri, D.; Ahmad, A.; Cuzzocrea, S.; Esposito, E. The renal injury and inflammation caused by ischemia–reperfusion are reduced by genetic inhibition of TNF- αR1: A comparison with infliximab treatment. Eur. J. Pharmacol. 2013, 700, 134–146.
[19] Wu, Y. X.; Li. C. Y.; Deng, Y. L. Patients with nephrolithiasis had lower fetuin-A protein level in urine and renal tissue. Urolithiasis 2014, 42, 29–37.
[20] Wang, J.; Zhang, Q. B.; Zhang, Z. S.; Zhang, H.; Niu, X. Z. Structural studies on a novel fucogalactan sulfate extracted from the brown seaweed Laminaria japonica. Int. J. Biol. Macromol. 2010, 47, 126–131.
[21] Samee, H.; Li, Z. X.; Lin, H.; Khalid, J.; Wang, B. P. In vivo study of antiallergenicity of ethanol extracts from Sargassum tenerri-mum, Sargassum cervicorne and Sargassum graminifolium turn. Eur. Food Res. Technol. 2009, 229, 435–441.
[22] Zhang, C. Y.; Wu, W. H.; Lan, M. B. Antioxidant properties of polysaccharide from the brown Seaweed Sargassum graminifolium (Turn.), and its effects on calcium oxalate crystallization. Mar. Drugs 2012, 10, 119–130.
[23] Zhang, C. Y.; Kong T.; Wu, W. H.; Lan, M. B. The Protection of Polysaccharide from the Brown Seaweed Sargassum graminifolium against Ethylene Glycol-Induced Mitochondrial Damage. Mar. Drugs 2013, 11, 870–880.
[24] Orhan, N.; Onaran, M.; ?en, ?.; Aslan, M. Preventive treatment of calcium oxalate crystal deposition with immortal flowers. J. Ethnopharmacol. 2015, 163, 60–67.
[25] Yuen, J. W. M.; Gohel, M. D. I.; Poon, N. W.; Shum, D. K. Y.; Tam, P. C.; Au, D. W. T. The initial and subsequent inflammatory events during calcium oxalate lithiasis. Clin. Chim. Acta 2010, 411, 1018–1026.
[26] Parveen, K. G.; Santosh, K. V.; Anil, K. S. Optimization of extraction protocol of Parmelia perlata and its validation for protective effects against oxalate-induced renal injury in NRK-52E cells. J. Herb. Med. 2018, 12, 79–87.
[27] :Mulay, S. R.; Kulkarni, O. P.; Rupanagudi, K. V.; Migliorini, A.; Darisipudi, M. N.; Vilaysane, A.; Muruve, D.; Shi, Y.; Munro, F.; Liapis, H.; Anders, H. J. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1beta secretion. J. Clin. Invest. 2013, 123, 236–246.
[28] Khan, S. R. Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl. Androl. Urol. 2014, 3, 256–276.
[29] Joshi, S.; Wang, W.; Peck, A. B.; Khan, S. R. Activation of the NLRP3 Inflammasome in Association with Calcium Oxalate Crystal Induced Reactive Oxygen Species in Kidneys. J. Urol. 2015, 193, 1684–1691.
[30] Ligon, C. B.; Hummers, L. K.; McMahan, Z. H. Oxalate nephropathy in systemic sclerosis: Case series and review of the literature. Semin. Arthritis Rheum. 2015, 45, 315–320.
[31] Veena, C. K.; Josephine, A.; Preetha, S. P.; Rajesh, N. G.; Varalakshmi, P. Mitochondrial ysfunction in an animal model of hyperoxaluria: A prophylactic approach with fucoidan. Eur. J. Pharmacol. 2008, 579, 330–336.
[32] Bayir, Y.; Halici, Z.; Keles, M.S.; Colak, S.; Cakir, A.; Kaya, Y.; Akçay, F. Helichrysum plicatum DC. subsp. plicatum extract as a preventive agent in experimentally induced urolithiasis model. Ethnopharmacology 2011, 138, 408–414.
[33] Bhadja, P.; Lunagariya, J.; Ouyang, J. M. Seaweed sulphated polysaccharide as an inhibitor of calcium oxalate renal stone formation. J. Funct. Foods 2016, 27, 685–694
[34] Ratkalkar, V. N.; Kleinman, J. G. Mechanisms of Stone Formation. Clin. Rev. Bone Miner. 2011, 9, 187–197. |